Earnings Call
Jul 29, 2026
Q2 FY2026
EPS Estimate
2.11
EPS Actual
2.32
Post-Earnings Close
$229.52
Earnings Reaction
+2.2%
IDEX's second quarter results mark a meaningful inflection point for the company, with organic order growth of 28%, the headline number that arguably matters more than any single earnings figure this quarter. Record orders of over $1 billion across the enterprise, with Health & Science Technologies (HST) posting 47% organic order growth, signal that the multi-year portfolio repositioning toward data center, semiconductor, and space and defense is now generating tangible commercial momentum rather than just strategic narrative. Adjusted EPS of $2.32 came in well ahead of the guided range of $2.07, $2.12, with organic revenue growing 5% and adjusted EBITDA margin expanding 70 basis points year-over-year to 28.1%. Management was transparent in flagging that IEEPA tariff refunds contributed $0.08 to EPS and 130 basis points to EBITDA margin in the quarter; even stripping those out, results were materially ahead of guidance.
Report generated on Jul 29, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full IEX analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.